Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
July 31, 2026Intestinal ResearchOpen Access

Upadacitinib in Asian inflammatory bowel disease practice: encouraging real-world efficacy

View Full Paper
Ask AI
Bookmark
Share

Authors

EKEun Soo Kim

Discussion

Loading...

Member takes

Overview

Real-world efficacy of upadacitinib shows meaningful symptom relief in patients with advanced IBD therapies, indicating its potential.

Key Points

  • Evaluate the real-world efficacy of upadacitinib in patients with inflammatory bowel disease who have failed multiple biologic therapies.
  • Observational study of biologic-experienced patients with inflammatory bowel disease at tertiary referral centers.
  • Emphasized collection of symptom-based patient-reported outcomes (PROs).
  • Assessed changes in diarrhea frequency, abdominal pain, and other symptoms contrary to traditional metrics.
  • Observed high remission rates, which should be interpreted cautiously due to variability in endpoint definitions.
  • Notable improvements in symptom relief, particularly in diarrhea frequency and abdominal pain were reported.
  • Efficacy retained even in patients with a history of multiple biologic failures.

Cite This Study

Eun Soo Kim (2026) studied this question.

synapsesocial.com/papers/6a6c46e6747664a1aa73bcc2https://doi.org/10.5217/ir.2026.00200
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prospective Bi-Centric Real-World Outcomes of Upadacitinib in Biologic-Experienced Patients with Crohn’s Disease2026 · 1 citations
  2. 2Efficacy and Safety of Upadacitinib for Refractory Inflammatory Bowel Disease: A Multicenter Real-World Observational Study2026
  3. 3Upadacitinib in Biologic-Experienced Inflammatory Bowel Disease: Real-World Efficacy, Safety, and Laboratory Outcomes2025 · 2 citations
  4. 4P0683Efficacy and Safety of Upadacitinib in Difficult-to-Treat Inflammatory Bowel Disease: A Prospective, Multicenter, Real-World Study (EaseUpIBD Study)2026
  5. 5A Real-World Study of Upadacitinib in Anti-TNF Refractory Crohn’s Disease: Effectiveness, Persistence, and Safety2026 · 1 citations